Marshall Wace
CTIC

Marshall Wace’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Marshall Wace’s Portfolio CTIC Stock Details CTIC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$25M Buy
2022
Q2 		– Sell
2022
Q1 		$4.03M Buy
2021
Q4 		$221K Buy
2017
Q1 		– Sell
2016
Q4 		$60K Buy